Connect with us

Health

TGA beings ‘first step’ in approval process for new COVD drug – Daily Telegraph

A new drug to treat COVID-19 has been expedited by the Therapeutic Goods Administration with SOTROVIMAB – developed by pharmaceutical company GlaxoSmithKline -…

Published

on

ADVERTISEMENT

A new drug to treat COVID-19 has been expedited by the Therapeutic Goods Administration with SOTROVIMAB – developed by pharmaceutical company GlaxoSmithKline – shown to reduce hospitalisations among COVID patients by 85 per cent.
GSK Medical Lead of COVID Therapeutics Krystal Evans said, “we were very encouraged by the announcement last week from the TGA that our COVID-19 monoclonal antibody has been granted this provisional designation.”
“It’s the first time that a monoclonal antibody has gone…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending